STEVEN POWELL: Open Payments
NPI 1548247356 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 22 payments from 7 companies in 2025. Trend: 2023 $29 · 2024 $343 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 8 | $325 |
| Janssen Pharmaceuticals, Inc | 5 | $192 |
| Supernus Pharmaceuticals, Inc. | 5 | $152 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
Products named: SUBLOCADE, SPRAVATO, Qelbree, REXULTI, BRIXADI, TRINTELLIX, VRAYLAR.
Industry payments across TX — which companies pay providers there.
